Is Quantum-Si incorporated (QSI) a Buy, Sell, or Hold?
Quantum-Si incorporated
NASDAQ:QSI
$0.862 USD
$0.0 (-0.48%)
- Volume
- 2.24M
- Average Volume
- 6.13M
- Market Capitalization
- $170.52M
- P/E Ratio
- -1.68
- Dividend Yield
- 0.00%
- Price Target
- $1.00
- Year High
- $3.10
- Year Low
- $0.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $12.60
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Jeffrey Alan Hawkins |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | QSI |
| CUSIP | 74765K105 |
| CIK | 0001816431 |
| Web | https://www.quantum-si.com |
| Phone | 203 458 7100 |
| Currency | USD |
| Employees | 145 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.02 |
| Payout Ratio | 0.00 |
| Current Ratio | 12.60 |
| Quick Ratio | 12.40 |
| Cash Ratio | 3.38 |
Sales & Book Value
| Annual Sales | $2.44M |
| Price / Sales | 92.08 |
| Cash Flow | -0.44 |
| Price / Cash Flow | -1.78 |
| Price / Book | 0.93 |
Price Target and Rating
| Average Stock Price Forecast | $1.00 |
| High Stock Price Forecast | $1.00 |
| Low Stock Price Forecast | $1.00 |
| Forecast Upside/Downside | -13.80% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 2 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.51 |
| Trailing P/E Ratio | -1.68 |
| PEG Ratio | -0.06 |
| P/E Growth | -0.06 |
| Net Income | $-101.34M |
| Net Margin | -5605.89% |
| Pretax Margin | -5609.94% |
| Return on Equity | -47.35% |
| Return on Assets | -48.66% |
Financials Score
| AltmanZ Score | 2.61 |
| Piotroski Score | 1.00 |
| Working Capital | 124.26M |
| Total Assets | 213.35M |
| Ebit | -96.3M |
| Market Cap | 170.52M |
| Total Liabilities | 12.6M |
Poll Results
About Quantum-Si incorporated (NASDAQ:QSI) Stock
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut. ...
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-16 16:05:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
2026-06-10 08:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™.
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
2026-06-03 09:00:00
[url="]Quantum-Si Incorporated[/url] (Nasdaq: QSI) (âQuantum-Si,â âQSIâ or the âCompanyâ), a proteomics technology company redefining protein analy
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
2026-06-03 08:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Expansion of the Proteus™ Roadshow.
2026-05-27 04:00:00
LONDON--(BUSINESS WIRE)-- #5G--Adtran and euNetworks today announced their collaboration on the launch of a new quantum-safe private connectivity service, Quantum Shield. euNetworks has developed Quantum Shield using Adtran's optical transport technology to augment its broader architecture, which is designed to deliver secure, scalable data center connectivity across euNetworks' pan-European network. The new offering is built for enterprises with stringent security, performance and customer-controlle.
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
2026-05-15 14:30:46
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-13 21:00:00
[url="]Quantum-Si Incorporated[/url] (Nasdaq: QSI) (âQuantum-Si,â âQSIâ or the âCompanyâ), a proteomics company redefining protein analysis through
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-13 20:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Frequently Asked Questions
-
What is the current Quantum-Si incorporated (QSI) stock price?
-
Quantum-Si incorporated(NASDAQ:QSI) stock price is $0.862 in the last trading session. During the trading session, QSI stock reached the peak price of $3.1 while $0.691 was the lowest point it dropped to. The percentage change in QSI stock occurred in the recent session was --0.48% while the dollar amount for the price change in QSI stock was -$-0.0.
-
QSI's industry and sector of operation?
-
The NASDAQ listed QSI is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of QSI?
-
Jeffry R. Keyes | Chief Financial Officer & Treasurer
Christian Lapointe | General Counsel & Corporate Secretary
Jonathan Rothberg | Founder & Executive Director
John S. Vieceli | Chief Product Officer
Lindsay Thompson | Chief Human Resources Officer -
How many employees does QSI have?
-
Number of QSI employees currently stands at 145. QSI operates from 530 Old Whitfield Street, Guilford, CT 06437, US.
-
Link for QSI official website?
-
Official Website of QSI is: https://www.quantum-si.com
-
How do I contact QSI?
-
QSI could be contacted at phone #203 458 7100 and can also be accessed through its website. QSI operates from 530 Old Whitfield Street, Guilford, CT 06437, US.
-
How many shares of QSI are traded daily?
-
The average number of QSI shares traded daily for last 3 months was 6.13M.
-
What is the market cap of QSI currently?
-
The market value of QSI currently stands at $170.52M with its latest stock price at $0.862